NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
Awarded by NHS England · to CSL Behring UK Ltd · 2024-12-19T00:00:00Z · £905,187,090
Description
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin Offer reference number: CM/PHS/23/5703 The period of the framework is 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months.
- Supplier
- CSL Behring UK Ltd
- Buyer
- NHS England
- Value
- £905,187,090
- Category (CPV)
- Immunoglobulins
- Award date
- 2024-12-19T00:00:00Z
- Buyer constituency
- runcorn-and-helsby
Full CPV hierarchy, related awards from the same supplier and buyer, and any declared MP interest overlaps load below when JavaScript is enabled.